Posted by Ethan Ryder on Jan 15th, 2025
On January 7, 2025, NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) filed a Form 8-K with the Securities and Exchange Commission, announcing the resignation of Janet Rehnquist as a member of the Board of Directors. The resignation, effective...
More of this article »